Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
orfiril magasýruþolin tafla 150 mg
desitin arzneimittel gmbh - natrii valproas - magasýruþolin tafla - 150 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
orfiril magasýruþolin tafla 600 mg
desitin arzneimittel gmbh - natrii valproas - magasýruþolin tafla - 600 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
orfiril mixtúra, lausn 60 mg/ml
desitin arzneimittel gmbh - natrii valproas - mixtúra, lausn - 60 mg/ml
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
orfiril retard forðatafla 300 mg
desitin arzneimittel gmbh - natrii valproas - forðatafla - 300 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
trilafon dekanoat (trilafon dekanoat) stungulyf, lausn 108 mg/ml
orion corporation - perphenazinum dekanóat - stungulyf, lausn - 108 mg/ml
European Union -
Icelandic -
EMA (European Medicines Agency)
nuedexta
jenson pharmaceutical services limited - dextromethorphan, kínidín - neurobehavioral manifestations - Önnur lyf í taugakerfinu - nuedexta er ætlað til einkenna meðferðar á pseudobulbar áhrifum (pba) hjá fullorðnum. verkun hefur aðeins verið rannsökuð hjá sjúklingum með undirliggjandi amyotrophic lateral sclerosis eða mænusigg.
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
peratsin húðuð tafla 2 mg
orion corporation - perphenazinum inn - húðuð tafla - 2 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
rimactan hart hylki 300 mg
sandoz gmbh* - rifampicinum inn - hart hylki - 300 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
rimactan hart hylki 150 mg
sandoz gmbh* - rifampicinum inn - hart hylki - 150 mg
Iceland -
Icelandic -
LYFJASTOFNUN (Icelandic Medicines Agency)
peratsin húðuð tafla 4 mg
orion corporation - perphenazinum inn - húðuð tafla - 4 mg